Tag Archives: oral treatment

Specialty Drug

JNJ’s UPTRAVI (selexipag) Receives FDA Approval for Intravenous Use in Adults

Posted on by John Santilli
02
Aug

The FDA approved UPTRAVI® (selexipag) injection for intravenous (IV) use for the treatment of pulmonary arterial hypertension (PAH, WHO Group I) in adult patients with WHO functional class (FC) II–III, who are temporarily unable to take oral therapy

Continue reading →
Specialty Drug, Specialty HUBs, Specialty Pharmacy

BioCryst’s Orladeyo Offers an Oral Treatment for HAE Patients

Posted on by John Santilli
01
Mar

According to BioCryst Pharmaceuticals, the maker of Orladeyo, the medicine will be provided exclusively by specialty pharmacy Optime Care

Continue reading →